• Issue

    Inflammatory Bowel Diseases: Volume 18, Issue 1

    1-195, E196-E200
    January 2012
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Clinical Articles

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE†

Robert Löfberg MD, PhD,  Edouard V. Louis MD, PhD,  Walter Reinisch MD,  Anne M. Robinson PharmD,  Martina Kron PhD,  Anne Camez MD,  Paul F. Pollack MD, 
  • Pages: 1-9
  • First Published: 23 February 2011

Predictors of adalimumab dose escalation in patients with crohn's disease at a tertiary referral center†

Russell D. Cohen MD,  Jeffrey R. Lewis MD,  Hannah Turner,  Laura E. Harrell MD,  Stephen B. Hanauer MD,  David T. Rubin MD, 
  • Pages: 10-16
  • First Published: 31 March 2011

Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease†

Toshiaki Watanabe MD, PhD,  Iwao Sasaki MD, PhD,  Akira Sugita MD, PhD,  Kohei Fukushima MD, PhD,  Kitaro Futami MD, PhD,  Toshifumi Hibi MD, PhD,  Mamoru Watanabe MD, PhD, 
  • Pages: 17-24
  • First Published: 04 March 2011

Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease†

Jennifer C.C. deBruyn MD,  Robert Hilsden MD, PhD,  Kevin Fonseca PhD,  Margaret L. Russell MD, PhD,  Gilaad G. Kaplan MD,  Otto Vanderkooi MD,  Iwona Wrobel MD, 
  • Pages: 25-33
  • First Published: 06 April 2011

Inadequate knowledge of immunization guidelines: A missed opportunity for preventing infection in immunocompromised IBD patients†‡

James H. Yeung MD,  Karen J. Goodman PhD,  Richard N. Fedorak MD, 
  • Pages: 34-40
  • First Published: 18 February 2011

Editorials

Immunizations and IBD: Whose responsibility is it? If I'm the prescribing doctor, shouldn't it be mine?

Gil Y. Melmed MD, MS, 
  • Pages: 41-42
  • First Published: 23 February 2011

Original Clinical Articles

Perianal Crohn's disease findings other than fistulas in a population-based cohort†‡§

Laurent Peyrin-Biroulet MD, PhD,  Edward V. Loftus Jr MD,  William J. Tremaine MD,  W. Scott Harmsen MS,  Alan R. Zinsmeister PhD,  William J. Sandborn MD, 
  • Pages: 43-48
  • First Published: 23 February 2011

Changing shape of disease: Nonalcoholic fatty liver disease in Crohn's disease—A case series and review of the literature†

Christopher E. McGowan MD,  Patricia Jones MD,  Millie D. Long MD, MPH,  A. Sidney Barritt IV MD, MSCR, 
  • Pages: 49-54
  • First Published: 23 February 2011

Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions

Dan Turner MD, PhD,  Anne M. Griffiths MD,  Thomas D. Walters MD,  Tong Seah,  James Markowitz MD,  Marian Pfefferkorn MD,  David Keljo MD,  Jacob Waxman,  Anthony Otley MD, MSc,  Neal S. LeLeiko MD, PhD,  David Mack MD,  Jeffrey Hyams MD,  Arie Levine MD, 
  • Pages: 55-62
  • First Published: 23 February 2011

Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease

Liang Ding PhD,  Fang-bin Zhang MD,  Hui Liu MS,  Xiang Gao MD,  Hui-chang Bi PhD,  Xue-ding Wang PhD,  Bai-li Chen MD,  Yu Zhang PhD,  Li-zi Zhao PhD,  Guo-ping Zhong PhD,  Pin-jin Hu MD,  Min-hu Chen MD,  Ming Huang PhD, 
  • Pages: 63-73
  • First Published: 04 March 2011

Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn's disease: A prospective comparative study versus intraoperative findings

Nadia Pallotta MD, PhD,  Giuseppina Vincoli MD,  Chiara Montesani MD,  Piero Chirletti MD,  Annamaria Pronio MD,  Roberto Caronna MD,  Barbara Ciccantelli MD,  Erminia Romeo MD,  Adriana Marcheggiano MD,  Enrico Corazziari MD, 
  • Pages: 74-84
  • First Published: 21 March 2011

Original Basic Science Articles

Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor-β-deficient mice†

Gijs Hardenberg PhD,  Yu Yao BSc,  Ciriaco A. Piccirillo PhD,  Megan K. Levings PhD,  Theodore S. Steiner MD, 
  • Pages: 85-93
  • First Published: 29 October 2011

miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes†

Joel R. Pekow MD,  Urszula Dougherty MS,  Reba Mustafi PhD,  Hongyan Zhu MD, PhD,  Masha Kocherginsky PhD,  David T. Rubin MD,  Stephen B. Hanauer MD,  John Hart MD,  Eugene B. Chang MD,  Alessandro Fichera MD,  Loren J. Joseph MD,  Marc Bissonnette MD, 
  • Pages: 94-100
  • First Published: 06 May 2011

Loss of downregulated in adenoma (DRA) impairs mucosal HCO3− secretion in murine ileocolonic inflammation†‡

Fang Xiao,  Marina Juric,  Junhua Li,  Brigitte Riederer,  Sunil Yeruva,  Anurag Kumar Singh,  Lifei Zheng,  Silke Glage,  George Kollias,  Pradeep Dudeja,  De-An Tian,  Gang Xu,  Jinxia Zhu,  Oliver Bachmann,  Ursula Seidler, 
  • Pages: 101-111
  • First Published: 06 May 2011

The bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease† ‡

Lijian Wang MD, ScD,  Estela Trebicka BS,  Ying Fu MD, PhD,  Shiri Ellenbogen MSc, ND,  Charles C. Hong MD, PhD,  Jodie L. Babitt MD,  Herbert Y. Lin MD, PhD,  Bobby J. Cherayil MD, 
  • Pages: 112-119
  • First Published: 23 February 2011

Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease

Antonio Altadill MD,  Noemí Eiró MSc,  Luis Ovidio González MD,  Sara Junquera MD,  José Manuel González-Quintana AAS,  María Rosario Sánchez MD, PhD,  Alejandro Andicoechea MD, PhD,  Cristina Saro MD, PhD,  Luis Rodrigo MD, PhD,  Francisco José Vizoso MD, PhD, 
  • Pages: 120-130
  • First Published: 15 March 2011

Consumption of probiotics increases the effect of regulatory T cells in transfer colitis

Emil Rathsach Petersen BSc,  Mogens Helweg Claesson DMSc,  Esben Gjerløff Wedebye Schmidt MSc,  Simon Skjøde Jensen MSc, PhD,  Peter Ravn MSc, PhD,  Jørgen Olsen DMSc,  Arthur C. Ouwehand MSc, PhD,  Nanna Ny Kristensen MSc, PhD, 
  • Pages: 131-142
  • First Published: 14 April 2011

Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis†

Kristin Lohr BS,  Hardik Sardana MBBS,  Seakwoo Lee PhD,  Feng Wu PhD,  David L. Huso PhD,  Abdel Rahim Hamad PhD,  Shukti Chakravarti PhD, 
  • Pages: 143-151
  • First Published: 11 April 2011

Consensus Reports

Free Access

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report

Brian G. Feagan MD,  Marc Lémann MD,  Ragnar Befrits MD, PhD,  William Connell MD,  Geert D'Haens MD, PhD,  Subrata Ghosh MD,  Pierre Michetti MD,  Thomas Ochsenkühn MD,  Remo Panaccione MD,  Stefan Schreiber MD,  Mark Silverberg MD, PhD,  Dario Sorrentino MD,  C. Janneke van der Woude MD, PhD,  Severine Vermeire MD, PhD,  Paul Rutgeerts MD, PhD, 
  • Pages: 152-160
  • First Published: 29 October 2011

Clinical Reviews

Inflammatory bowel disease-associated thromboembolism: A systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis

James H. Tabibian MD,  Michael B. Streiff MD, 
  • Pages: 161-171
  • First Published: 29 July 2011

Editorials

Treatment of thromboembolism in IBD: More questions than answers

Geoffrey C. Nguyen MD, PhD, FRCPC, 
  • Pages: 172-173
  • First Published: 02 February 2011

Clinical Reviews

Free Access

Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

Kofi Clarke MD,  Miguel Regueiro MD, 
  • Pages: 174-179
  • First Published: 14 June 2011

Basic Science Reviews

Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease

Gheorghe Hundorfean MD,  Markus F. Neurath MD, PhD,  Jonas Mudter MD, 
  • Pages: 180-186
  • First Published: 04 March 2011

MicroRNAs in inflammatory bowel disease

Joel R. Pekow MD,  John H. Kwon MD, PhD, 
  • Pages: 187-193
  • First Published: 18 March 2011

Selected Summaries

Managing postoperative clinical recurrence of Crohn's disease: Is it time to shift our paradigm?

Jonathan S. Levine MD, 
  • Pages: 194-195
  • First Published: 20 May 2011

Letters to the Editor

Should we monitor Crohn's disease patients for postoperative recurrence after permanent ileostomy?

Carles Leal-Valdivieso MD,  Íngrid Marín MD,  Míriam Mañosa MD, PhD,  Juan Enrique Naves MD,  Yamile Zabana MD,  Marta Piñol MD, PhD,  Eduard Cabré MD, PhD,  Eugeni Domènech MD, PhD, 
  • Page: E196
  • First Published: 10 October 2011

Systemic Bartonella henselae infection and Crohn's disease treatment with infliximab

Alex Cañas-Ventura MD,  Erika Esteve MD,  Juan P. Horcajada MD, PhD,  Montserrat Andreu MD, PhD,  Hernando Knobel MD, PhD,  Lucía Márquez MD, 
  • Pages: E197-E198
  • First Published: 16 September 2011

Malignant melanoma during ustekinumab therapy of Crohn's disease

Laura M. Ehmann MD,  Cornelia Tillack-Schreiber MD,  Stephan Brand MD, Prof,  Andreas Wollenberg MD, Prof, 
  • Pages: E199-E200
  • First Published: 10 October 2011